FIP Ankara 2019

B2 - Access to medicines: Healthcare systems’ sustainability

Meeting room: Hippokrates

Rapporteur: Ebru Erdağ, Department of Economic Evaluations and Medicines Supply Management, Turkish Medicines and Medical Devices Agency, Turkey

Chairs

Roza Yagudina, President, Moscow Pharmaceutical Society, Russian Federation, Russia and Serif Boyaci, Former Audit Committee Member, Turkish Pharmacist' Association, FIP Fellow, Turkey

Introduction

Supported by the European Federation of Pharmaceutical Industries and Associations (EFPIA)

Target audience: Community pharmacy, Hospital pharmacy, Industrial pharmacy, Social and Administrative Pharmacy, Policy and regulation

 

WHO estimates that more than half of all medicines worldwide are prescribed, dispensed or sold inappropriately, and that half of all patients fail to take medicines correctly. Overuse, underuse and misuse result in wastage of scarce resources, continued health problems or adverse reactions to drugs. Pharmacists have significant roles in improving patients’ access to medicines and ensuring healthcare systems sustainability through rational use of medicines and keeping medicines fairly affordable. In this session key organisations from Europe will present their policy principles and discuss key barriers and enablers for pharmacists in healthcare systems’ sustainability.

Programme

14:00 – 14:05     Introduction by chairs

14:05 – 14:20     Patient access to medicines and healthcare system sustainability

Virginia Acha, Chair, EFPIA International Regulatory Turkey Network and Executive Director, Global Regulatory Policy, MSD, UK

14:20 – 14:35    Access to essential health products and the role of reimbursement policies in WHO European Region

Tifenn Humbert, Technical Officer, Health Technologies and Pharmaceuticals, Division of Health Systems and Public Health, WHO Regional Office for Europe, Denmark

14:35 – 14:50     The main challenge in pricing and reimbursement policies for medicines: Value for Money

Zafer Caliskan, Faculty Member, Hacettepe University Faculty of Economics and Administrative Sciences, Turkey

14.50 – 15.30     Moderated discussion with speakers and audience

Learning Objectives

At the end of this session, participants will be able to:

  1. Identify the key barriers for patient access to medicines in Europe.
  2. Identify new ways for pharmacists to improve healthcare systems’ sustainability.
  3. Describe how different stakeholders could more effectively collaborate and contribute to faster and wider access to medicines for patients.